Developer docs
API playgroundTry for free, no card

Search company profiles

TriNetX

Full company profile

uuid000091v

Namestring
TriNetX
Legal namestring
TriNetX, LLC
Websiteurl
trinetx.com
Company typeenum
Private
Founded yearint
2013
Descriptiontext

TriNetX is a privately held healthcare technology company that operates a global federated real-world data network connecting pharmaceutical companies, contract research organizations, healthcare providers, and academic researchers to a pool of more than 300 million de-identified patient records spanning 20+ countries and 13,000+ clinical sites. Its core platform, TriNetX LIVE™, is a web-based, no-code interface that enables cohort definition, feasibility analysis, site identification, and patient recruitment support for clinical trials, with patient data remaining within source healthcare organizations and queries traveling to the data through an OMOP-harmonized federated architecture. The product suite is layered: the core LIVE platform is complemented by downloadable datasets (TriNetX Dataworks™), linked EHR-plus-claims longitudinal datasets (TriNetX Linked™), the EVIDEX® pharmacovigilance signal-detection platform (acquired from Advera Health Analytics in 2022), the XetaBase multiomic analytics platform (acquired from Zetta Genomics in 2026), and expert consulting services.

Short descriptiontext

TriNetX is a privately held healthcare technology company that operates a global federated real-world data network of 300M+ patients across 20+ countries, serving pharmaceutical companies, CROs, healthcare providers, and academic researchers with clinical trial planning, site identification, and real-world evidence generation tools.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersCambridge, United States
HQ citystring
Cambridge
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical trial data, real-world evidence, federated health data, pharmacovigilance analytics, patient cohort analysis
Industry2 codes
PRIMARYHLALAKAH
Clinical Triage, Care Navigation & Routing Engines
Healthcare & Life Sciences/Telehealth Platforms/Telehealth Infrastructure & Enablement Platforms (video, scheduling, EHR integration)
SECONDARYHLACAGAA
Diagnostic & Triage Decision Support
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools
NAICS code2 codes
  • Medical and Diagnostic Laboratories62151
  • Computer Systems Design and Related Services54151
SIC code1 code
  • Services-Medical Laboratories8071
Product category
Clinical Research Data Platform
Social media profiles3 records
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1TriNetX LIVE™ Subscription
TypeSubscription Recurring
Description

Subscription-based access to the federated health data network platform for querying patient populations, site identification, and clinical trial feasibility analysis. Likely operates on annual subscription contracts with enterprise clients.

trinetx.com
2Dataset Licensing
TypeSubscription Recurring
Description

Fine-grained, date-stamped de-identified EHR patient datasets (Dataworks™ and Linked™) provided to clients for internal analysis. Data is refreshed regularly (every 3-4 weeks) and available for specific therapeutic areas or pan-therapeutic analyses.

trinetx.com
3EVIDEX® Platform Access
TypeSubscription Recurring
Description

Pharmacovigilance signal detection and management platform subscription providing access to safety databases, automated workflows, and compliance tools.

trinetx.com
4Consulting Services
TypeProfessional Services
Description

Expert consulting services for regulatory engagements, study design, real-world evidence research, external control arms, and epidemiological services.

trinetx.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Pricing details1 tier
1Enterprise subscription model with customized pricing
ModelSubscriptionBilling cadenceAnnual
Notes

No specific pricing tiers publicly available. Pricing appears to be negotiated based on client size, data access requirements, and service scope.

trinetx.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1TriNetX LIVE™
Description

The powerful, no-code real-world data platform for clinical research, connecting researchers to over 300 million global patients through an intuitive, web-based interface.

trinetx.com
+3 more records
Core offering1 text field

TriNetX operates a global federated health data network connecting 240+ healthcare organizations across 20+ countries with pharmaceutical companies, biotech firms, and academic researchers. The platform enables real-time querying of de-identified patient records (300M+) for clinical trial feasibility, site identification, patient recruitment, and real-world evidence generation. Supporting offerings include downloadable datasets (TriNetX Dataworks™, TriNetX Linked™), the EVIDEX® pharmacovigilance signal detection platform, the XetaBase multiomic analytics platform, and expert consulting services for regulatory engagements and study design.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 8 values shown
  • Protocol amendments reduced by up to 50%
+7 more records
Product overview1 text field

TriNetX operates as a federated health data network company offering a platform-plus-modules architecture. The core product is TriNetX LIVE™, a web-based platform connecting to over 318 million de-identified patient records across 20+ countries, which provides cohort definition, site identification, and real-world evidence generation capabilities. Supporting modules include TriNetX Dataworks™ (downloadable datasets), TriNetX Linked™ (linked claims and EHR data), and EVIDEX® (pharmacovigilance signal detection, originally from Advera Health Analytics acquisition). The company also offers Consulting Services with world-renowned scientific experts and acquired Zetta Genomics' XetaBase platform for multiomic data capabilities. Additional products span Analytics modules (Query Builder, Basic Analytics, Advanced Analytics), collaboration tools (CONNECT), Premium Services, and the TriNetX API for system integration. Data is refreshed every 3-4 weeks and harmonized to OMOP common data model standards.

Product and service7 records
1TriNetX LIVE™
CategoryReal-world data platform
Description

Web-based, no-code real-world data platform that connects researchers to over 300 million de-identified patient records worldwide for clinical trial feasibility analysis, cohort definition, site identification, and HEOR/regulatory evidence generation.

2TriNetX Dataworks™
CategoryReal-world data licensing
Description

Downloadable, row-level, de-identified EHR patient data offered in a ready-to-use format for analysis or incorporation into internal research platforms, with datasets aligned to specific therapeutic areas and refreshed every 3-4 weeks.

3TriNetX Linked™
CategoryReal-world data licensing
Description

Linked dataset combining enriched EHR with medical and pharmacy claims, mortality, and social determinants of health data to enable detailed longitudinal analysis of patient journeys, costs, and outcomes across care settings.

4Consulting Services
CategoryProfessional services
Description

Expert-led consulting services covering real-world evidence consulting, RWE research, external control arms, and epidemiological services for regulatory engagements, study design, and evidence generation, delivered by scientists ranked in the top 2% most-cited worldwide.

5TherapyMonitor™
CategoryReal-world data licensing
Description

European oncology data service providing patient-level insights from European oncology data, curated by Europe-based oncology experts for real-world analyses of disease prevalence, treatment patterns, and market dynamics.

6TriNetX API
CategoryDeveloper API
Description

Secure API that enables seamless integration of location-based patient data and standardized site intelligence into customers' own systems, allowing researchers to send study queries using medical codes or natural language to receive real-time patient counts, feasibility data, and site intelligence.

7XetaBase
CategoryGenomics analytics
Description

Multiomic capture and analytics platform enabling scalable genomic analysis across populations and supporting federated querying across genomic and phenotypic data at population scale.

Scale indicator12 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2026-04-07
Description

Acquisition of key assets from Zetta Genomics, a Cambridge UK-based healthcare technology company. The acquisition brought Zetta's XetaBase multiomic capture and analytics platform into TriNetX's ecosystem, enhancing genomics data management capabilities. Companies had collaborated since 2024 on federated querying across genomic and phenotypic data.

Strategic tierCoreTypeTechnology or Integration
Description

TriNetX uses Databricks' platform to accelerate drug development processes and improve clinical research efficiency. The collaboration has resulted in reducing protocol amendments by up to 50% and developing predictive models that forecast disease risks years in advance.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

TriNetX Chief Scientific Officer Jeffrey Brown collaborates with Dr. Miguel Hernán, Director of CAUSALab at Harvard, on frameworks for RWD study design and causal inference. Joint webinar planned for July 2026 on practical frameworks for designing rigorous RWD studies.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

IQVIA is the largest contract research organization and real-world evidence provider globally, combining clinical research services with proprietary RWD assets. It competes with TriNetX across clinical trial feasibility, RWE generation, and pharma data analytics, though it is a much broader incumbent with services across the full drug development lifecycle.

TypeDirect peer
Description

Flatiron Health (acquired by Roche) operates an oncology-focused real-world data platform aggregating EHR data from oncology clinics. It is a direct competitor in the RWD/RWE space, particularly for oncology trials, with a similar federated approach to oncology patient data.

TypeDirect peer
Description

ConcertAI is an oncology-focused real-world data and AI company serving pharma and providers, with a federated data network similar in concept to TriNetX LIVE. It directly competes for pharma RWD and clinical trial feasibility business in oncology.

TypeBroad incumbent
Description

Optum operates one of the largest U.S. claims and clinical data assets and competes with TriNetX for pharma RWD, outcomes research, and clinical trial enablement. It is a broad incumbent with significant data scale advantages via UnitedHealth's claims footprint.

5Tempus
TypeEmerging player
Description

Tempus combines molecular/clinical data with AI to support oncology and other therapeutic areas. It is an emerging player in the RWD/RWE space with strong genomics capabilities that increasingly overlaps with TriNetX's XetaBase multiomic offering.

TypeDirect peer
Description

Datavant provides health data connectivity and de-identification linking services across multiple data sources, similar to TriNetX's Linked™ dataset offering. It is a direct competitor in the federated/linked real-world data infrastructure layer.

TypeBroad incumbent
Description

Health Catalyst provides healthcare data and analytics infrastructure to providers and life sciences companies. While more provider-anchored, it competes with TriNetX in health data analytics and population-level insights.

TypeEmerging player
Description

COTA focuses on real-world oncology data and evidence generation for pharma, similar to ConcertAI and Flatiron. It is an emerging player competing for the same oncology RWE customers TriNetX serves.

TypeBroad incumbent
Description

Medidata is a clinical trial technology platform (Rave EDC, RTSM) that overlaps with TriNetX in clinical trial enablement workflows. Several TriNetX leaders (including COO Steve Kundrot) previously worked at Medidata, illustrating the operational overlap.

TypeBroad incumbent
Description

Veradigm combines EHR data with life sciences research enablement via its Veradigm Network and Real-World Data offerings. It competes with TriNetX for de-identified EHR data licensing and clinical research insights.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
Yes

Docs URL, Description

AI capability7 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles14 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries2 records

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

Compliance4 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A4 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

TriNetX

Clinical Research Data Platformtrinetx.com

TriNetX is a privately held healthcare technology company that operates a global federated real-world data network of 300M+ patients across 20+ countries, serving pharmaceutical companies, CROs, healthcare providers, and academic researchers with clinical trial planning, site identification, and real-world evidence generation tools.

What TriNetX does

TriNetX is a privately held healthcare technology company that operates a global federated real-world data network connecting pharmaceutical companies, contract research organizations, healthcare providers, and academic researchers to a pool of more than 300 million de-identified patient records spanning 20+ countries and 13,000+ clinical sites. Its core platform, TriNetX LIVE™, is a web-based, no-code interface that enables cohort definition, feasibility analysis, site identification, and patient recruitment support for clinical trials, with patient data remaining within source healthcare organizations and queries traveling to the data through an OMOP-harmonized federated architecture. The product suite is layered: the core LIVE platform is complemented by downloadable datasets (TriNetX Dataworks™), linked EHR-plus-claims longitudinal datasets (TriNetX Linked™), the EVIDEX® pharmacovigilance signal-detection platform (acquired from Advera Health Analytics in 2022), the XetaBase multiomic analytics platform (acquired from Zetta Genomics in 2026), and expert consulting services.

TriNetX firmographics

Firmographics
Name
TriNetX
Legal name
TriNetX, LLC
Website
https://trinetx.com
Company type
Private
Founded year
2013
Operating status
Operating
Headcount range
251–500 employees
Short description
TriNetX is a privately held healthcare technology company that operates a global federated real-world data network of 300M+ patients across 20+ countries, serving pharmaceutical companies, CROs, healthcare providers, and academic researchers with clinical trial planning, site identification, and real-world evidence generation tools.
Ownership category
akta.pro rank

TriNetX industry classification

Industry
Product category
Clinical Research Data Platform
NAICS
Medical and Diagnostic Laboratories (62151), Computer Systems Design and Related Services (54151)
SIC
Services-Medical Laboratories (8071)
akta.pro industry
PRIMARYHLALAKAH
Clinical Triage, Care Navigation & Routing Engines
Healthcare & Life Sciences/Telehealth Platforms/Telehealth Infrastructure & Enablement Platforms (video, scheduling, EHR integration)
SECONDARYHLACAGAA
Diagnostic & Triage Decision Support
Healthcare & Life Sciences/Digital Health & Health IT/Clinical Decision Support (CDS) & Care Pathway Tools

Keywords

  • Clinical trial data
  • Real-world evidence
  • Federated health data
  • Pharmacovigilance analytics
  • Patient cohort analysis

Where TriNetX is headquartered

Location

Headquarters

HQ city
Cambridge
HQ country
United States
HQ region
North America

Offices3 records

Markets served

TriNetX business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

  1. TriNetX LIVE™ Subscription: Subscription-based access to the federated health data network platform for querying patient populations, site identification, and clinical trial feasibility analysis. Likely operates on annual subscription contracts with enterprise clients.
  2. Dataset Licensing: Fine-grained, date-stamped de-identified EHR patient datasets (Dataworks™ and Linked™) provided to clients for internal analysis. Data is refreshed regularly (every 3-4 weeks) and available for specific therapeutic areas or pan-therapeutic analyses.
  3. EVIDEX® Platform Access: Pharmacovigilance signal detection and management platform subscription providing access to safety databases, automated workflows, and compliance tools.
  4. Consulting Services: Expert consulting services for regulatory engagements, study design, real-world evidence research, external control arms, and epidemiological services.

Pricing tiers

ModelBillingPrice
SubscriptionAnnualEnterprise subscription model with customized pricing

Go-to-market motion3 records

Distribution channels3 records

Marketing channels6 records

TriNetX product offering

Product offering

Core offering

TriNetX operates a global federated health data network connecting 240+ healthcare organizations across 20+ countries with pharmaceutical companies, biotech firms, and academic researchers. The platform enables real-time querying of de-identified patient records (300M+) for clinical trial feasibility, site identification, patient recruitment, and real-world evidence generation. Supporting offerings include downloadable datasets (TriNetX Dataworks™, TriNetX Linked™), the EVIDEX® pharmacovigilance signal detection platform, the XetaBase multiomic analytics platform, and expert consulting services for regulatory engagements and study design.

Product overview

TriNetX operates as a federated health data network company offering a platform-plus-modules architecture. The core product is TriNetX LIVE™, a web-based platform connecting to over 318 million de-identified patient records across 20+ countries, which provides cohort definition, site identification, and real-world evidence generation capabilities. Supporting modules include TriNetX Dataworks™ (downloadable datasets), TriNetX Linked™ (linked claims and EHR data), and EVIDEX® (pharmacovigilance signal detection, originally from Advera Health Analytics acquisition). The company also offers Consulting Services with world-renowned scientific experts and acquired Zetta Genomics' XetaBase platform for multiomic data capabilities. Additional products span Analytics modules (Query Builder, Basic Analytics, Advanced Analytics), collaboration tools (CONNECT), Premium Services, and the TriNetX API for system integration. Data is refreshed every 3-4 weeks and harmonized to OMOP common data model standards.

Differentiator

Problem solved

Functional benefit

Brands

  • TriNetX LIVE™: The powerful, no-code real-world data platform for clinical research, connecting researchers to over 300 million global patients through an intuitive, web-based interface.
  • EVIDEX®
  • TriNetX Dataworks™
  • TriNetX Linked™

Products and services

  • TriNetX LIVE™ Web-based, no-code real-world data platform that connects researchers to over 300 million de-identified patient records worldwide for clinical trial feasibility analysis, cohort definition, site identification, and HEOR/regulatory evidence generation.
  • TriNetX Dataworks™ Downloadable, row-level, de-identified EHR patient data offered in a ready-to-use format for analysis or incorporation into internal research platforms, with datasets aligned to specific therapeutic areas and refreshed every 3-4 weeks.
  • TriNetX Linked™ Linked dataset combining enriched EHR with medical and pharmacy claims, mortality, and social determinants of health data to enable detailed longitudinal analysis of patient journeys, costs, and outcomes across care settings.
  • Consulting Services Expert-led consulting services covering real-world evidence consulting, RWE research, external control arms, and epidemiological services for regulatory engagements, study design, and evidence generation, delivered by scientists ranked in the top 2% most-cited worldwide.
  • TherapyMonitor™ European oncology data service providing patient-level insights from European oncology data, curated by Europe-based oncology experts for real-world analyses of disease prevalence, treatment patterns, and market dynamics.
  • TriNetX API Secure API that enables seamless integration of location-based patient data and standardized site intelligence into customers' own systems, allowing researchers to send study queries using medical codes or natural language to receive real-time patient counts, feasibility data, and site intelligence.
  • XetaBase Multiomic capture and analytics platform enabling scalable genomic analysis across populations and supporting federated querying across genomic and phenotypic data at population scale.

Quantifiable outcome

  • Protocol amendments reduced by up to 50%
  • +7 more outcomes

Companies that use TriNetX

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

TriNetX technology and API

Technology

Technology focussed Yes

API detail

Has API
Yes
API docs
API detail

Core technology

AI maturity

App detail

AI capability7 records

Feature6 records

TriNetX partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core.

  • Zetta GenomicscoreTechnology or Integration · 7 April 2026Acquisition of key assets from Zetta Genomics, a Cambridge UK-based healthcare technology company. The acquisition brought Zetta's XetaBase multiomic capture and analytics platform into TriNetX's ecosystem, enhancing genomics data management capabilities. Companies had collaborated since 2024 on federated querying across genomic and phenotypic data.
  • DatabrickscoreTechnology or IntegrationTriNetX uses Databricks' platform to accelerate drug development processes and improve clinical research efficiency. The collaboration has resulted in reducing protocol amendments by up to 50% and developing predictive models that forecast disease risks years in advance.
  • Harvard T.H. Chan School of Public Health / CAUSALabcoreStrategic or Co-development PartnerTriNetX Chief Scientific Officer Jeffrey Brown collaborates with Dr. Miguel Hernán, Director of CAUSALab at Harvard, on frameworks for RWD study design and causal inference. Joint webinar planned for July 2026 on practical frameworks for designing rigorous RWD studies.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

TriNetX competitors and assessment

Company assessment

Broad incumbents

  • IQVIA: IQVIA is the largest contract research organization and real-world evidence provider globally, combining clinical research services with proprietary RWD assets. It competes with TriNetX across clinical trial feasibility, RWE generation, and pharma data analytics, though it is a much broader incumbent with services across the full drug development lifecycle.
  • Optum (UnitedHealth Group): Optum operates one of the largest U.S. claims and clinical data assets and competes with TriNetX for pharma RWD, outcomes research, and clinical trial enablement. It is a broad incumbent with significant data scale advantages via UnitedHealth's claims footprint.
  • Health Catalyst: Health Catalyst provides healthcare data and analytics infrastructure to providers and life sciences companies. While more provider-anchored, it competes with TriNetX in health data analytics and population-level insights.
  • Medidata Solutions (Dassault Systèmes): Medidata is a clinical trial technology platform (Rave EDC, RTSM) that overlaps with TriNetX in clinical trial enablement workflows. Several TriNetX leaders (including COO Steve Kundrot) previously worked at Medidata, illustrating the operational overlap.
  • Veradigm (Allscripts): Veradigm combines EHR data with life sciences research enablement via its Veradigm Network and Real-World Data offerings. It competes with TriNetX for de-identified EHR data licensing and clinical research insights.

Direct peers

  • Flatiron Health: Flatiron Health (acquired by Roche) operates an oncology-focused real-world data platform aggregating EHR data from oncology clinics. It is a direct competitor in the RWD/RWE space, particularly for oncology trials, with a similar federated approach to oncology patient data.
  • ConcertAI: ConcertAI is an oncology-focused real-world data and AI company serving pharma and providers, with a federated data network similar in concept to TriNetX LIVE. It directly competes for pharma RWD and clinical trial feasibility business in oncology.
  • Datavant: Datavant provides health data connectivity and de-identification linking services across multiple data sources, similar to TriNetX's Linked™ dataset offering. It is a direct competitor in the federated/linked real-world data infrastructure layer.

Emerging players

  • Tempus: Tempus combines molecular/clinical data with AI to support oncology and other therapeutic areas. It is an emerging player in the RWD/RWE space with strong genomics capabilities that increasingly overlaps with TriNetX's XetaBase multiomic offering.
  • COTA Healthcare: COTA focuses on real-world oncology data and evidence generation for pharma, similar to ConcertAI and Flatiron. It is an emerging player competing for the same oncology RWE customers TriNetX serves.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

TriNetX social profiles

Digital presence

TriNetX compliance and trust

Trust signal

Compliance4 records

TriNetX financial estimates

Financial estimate

Revenue estimate

Valuation estimate

TriNetX leadership team

Management profile

Number of profiles

Profiles14 records

TriNetX subsidiaries and ownership

Company hierarchy

Subsidiaries2 records

TriNetX funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

TriNetX M&A and investment

M&A and investment

M&A4 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about TriNetX

What does TriNetX do?

TriNetX operates a global federated health data network connecting 240+ healthcare organizations across 20+ countries with pharmaceutical companies, biotech firms, and academic researchers. The platform enables real-time querying of de-identified patient records (300M+) for clinical trial feasibility, site identification, patient recruitment, and real-world evidence generation. Supporting offerings include downloadable datasets (TriNetX Dataworks™, TriNetX Linked™), the EVIDEX® pharmacovigilance signal detection platform, the XetaBase multiomic analytics platform, and expert consulting services for regulatory engagements and study design.

Is TriNetX a public or private company?

TriNetX is a private company. It is classified as venture growth investor backed and is currently operating.

When was TriNetX founded?

TriNetX was founded in 2013. It employs 251 to 500 people.

Where is TriNetX based?

TriNetX is headquartered in Cambridge, United States, in the North America region.

How does TriNetX make money?

Four revenue lines are on record. TriNetX LIVE™ Subscription is the primary driver. The others are dataset Licensing, EVIDEX® Platform Access and consulting Services.

Who are TriNetX's main competitors?

Broad incumbents on record are IQVIA, Optum (UnitedHealth Group), Health Catalyst, Medidata Solutions (Dassault Systèmes) and Veradigm (Allscripts). Direct peers are Flatiron Health, ConcertAI and Datavant. Emerging players are Tempus and COTA Healthcare.

Does TriNetX have an API?

Yes. TriNetX API enables seamless integration of location-based patient data and standardized site intelligence into users' own systems. The API is part of TriNetX LIVE™ and allows pharmaceutical companies to access real-world data for clinical trial planning across a network spanning 300 million patients in more than 20 countries. The platform allows researchers to send study queries using medical codes or natural language directly from their own systems to receive real-time patient counts, feasibility data, and site intelligence. Enhanced API capabilities were recognized with the Clinical Trial Innovation Award in the 10th annual MedTech Breakthrough Awards program. Developer documentation is at trinetx.com/solutions/trinetx-live/api.

What industry is TriNetX in?

TriNetX's product category is Clinical Research Data Platform. Its primary akta.pro industry code is HLALAKAH, Clinical Triage, Care Navigation & Routing Engines, with a secondary code of HLACAGAA, Diagnostic & Triage Decision Support. Its NAICS code is 62151 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireTriNetX nombra a Carnell Elliott director comercialTriNetX named Carnell Elliott as commercial director, overseeing sales, global health alliances, and marketing. Elliott previously led a commercial team at Henry Schein One and increased Change Healthcare's contract value from $50M to $200M. He reports to CEO August Calhoun.LelezardTriNetX nomme Carnell Elliott au poste de directeur commercialTriNetX named Carnell Elliott as commercial director to lead sales, global healthcare partnerships, and marketing. Elliott previously led commercial teams at Henry Schein One and Change Healthcare, where he grew new contracts from $50M to $200M. He reports to CEO August Calhoun.PR Newswire APACTriNetX Names Carnell Elliott Chief Commercial OfficerTriNetX appointed Carnell Elliott as Chief Commercial Officer to lead sales, global healthcare partnerships, and marketing. Elliott previously led revenue at Henry Schein One and increased Change Healthcare bookings from $50 million to $200 million in total contract value.AktienTriNetX Names Carnell Elliott Chief Commercial OfficerTriNetX appointed Carnell Elliott as Chief Commercial Officer to lead sales, partnerships, and marketing. Elliott previously scaled Change Healthcare's bookings from $50 million to $200 million in total contract value. He reports to CEO August Calhoun.AktienTriNetX ernennt Carnell Elliott zum Chief Commercial OfficerTriNetX appointed Carnell Elliott as Chief Commercial Officer, effective immediately. Elliott will lead sales, global healthcare partnerships, and marketing, reporting to CEO August Calhoun. He previously led revenue at Henry Schein One and Change Healthcare, where he grew revenue from $50M to $200M.NewswireTriNetX Names Carnell Elliott Chief Commercial OfficerTriNetX appointed Carnell Elliott as Chief Commercial Officer to lead sales, healthcare partnerships, and marketing. Elliott previously scaled Change Healthcare's bookings from $50 million to $200 million in total contract value. He reports to CEO August Calhoun.PR NewswireTriNetX Names Carnell Elliott Chief Commercial OfficerTriNetX appointed Carnell Elliott as Chief Commercial Officer to lead sales, global healthcare partnerships, and marketing. Elliott previously led revenue at Henry Schein One and increased Change Healthcare bookings from $50 million to $200 million in total contract value.PR NewswireTriNetX ernennt Carnell Elliott zum Chief Commercial OfficerTriNetX appointed Carnell Elliott as Chief Commercial Officer, effective immediately. Elliott, previously VP of Revenue at Henry Schein One, will lead sales, global partnerships, and marketing. He reports to CEO August Calhoun.PR NewswireTriNetX nomme Carnell Elliott directeur commercialTriNetX named Carnell Elliott as commercial director to lead sales, partnerships, and marketing. Elliott previously led revenue at Henry Schein One and increased Change Healthcare's contract value from $50M to $200M. He reports to CEO August Calhoun.ScienmagRetinal Vasculitis in Autoimmune Disorders Linked to Doubled Long-TermA 20-year TriNetX study found patients with systemic lupus erythematosus and retinal vasculitis had an 8.3% 20-year stroke risk versus 3.8% without, a hazard ratio of 2.2. Similar elevated risks appeared in Behçet's disease, sarcoidosis, rheumatoid arthritis, and granulomatosis with polyangiitis. The authors recommend neurological vigilance and early stroke risk stratification.